Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesBreast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2
Breast Cancer Research and Treatment, 11/06/09
Domchek SM et al. – In this prospective study of women who were unaffected at the time of genetic testing and who were negative for the known familial mutation in BRCA1/2, no excess risk of invasive BC was observed. The data suggest that such women in the US should adhere to population–based guidelines for breast cancer screening.
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 86%
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study
Cancer Epidemiology, Biomarkers & Prevention, 10/01/09
Relevance Score: 85%
Breast-feeding the last born child and risk of ovarian cancer
Cancer Causes and Control, 11/16/09
Relevance Score: 84%
New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk
Archives of Internal Medicine, 10/13/09
Relevance Score: 84%
Novel breast tissue feature strongly associated with risk of breast cancer
Journal of Clinical Oncology, 10/08/09
Relevance Score: 84%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Borderline and malignant phyllodes tumors display similar promoter methylation profiles
Virchows Archiv, 11/25/09
Bevacizumab in the treatment of breast cancer
Cancer Treatment Reviews, 11/25/09
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer
Cancer, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor